A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/00 (2006.01) A61K 31/7088 (2006.01) A61K 38/17 (2006.01) A61K 38/20 (2006.01) C07K 14/47 (2006.01)
Patent
CA 2363269
A pro-inflammatory T cell response is specifically suppressed by the injection into a recipient of DNA encoding an autoantigen associated with autoimmune disease. The recipient may be further treated by co-vaccination with a DNA encoding a Th2 cytokine, particularly encoding IL4. In response to the vaccination, the proliferation of autoantigen-reactive T cells and the secretion of Th1 cytokines, including IL-2, IFN-.gamma. and IL-15, are reduced.
On élimine de manière spécifique une réponse de cellules T pro-inflammatoires en injectant à un récepteur de l'ADN codant pour un autoantigène associé à une maladie auto-immune. On peut aussi traiter le récepteur par co-vaccination avec de l'ADN codant pour une cytokine Th2, en particulier codant pour IL4. En réponse à la vaccination, la prolifération de cellules T réactives à l'autoantigène et la sécrétion de cytokines Th1, y compris IL-2, IFN-.gamma. et IL-15 sont réduites.
Garren Hideki
Ruiz Pedro Jose
Steinman Lawrence
Fetherstonhaugh & Co.
The Board Of Trustees Of The Leland Stanford Junior University
LandOfFree
Dna vaccination for treatment of autoimmune disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dna vaccination for treatment of autoimmune disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dna vaccination for treatment of autoimmune disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1593908